Delivery Order SPE2DE21D7010-SPE2D626F72R9
- Not listed
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products, was awarded a delivery order valued at $5,189.76 by the Defense Logistics Agency (DLA) Medical Supply Chain on September 2, 2025. The contract, designated as "SMALL INTERLOCK II," represents a fixed-price delivery order with economic price adjustment mechanisms and carries an ultimate completion date of September 22, 2025. The award was made without any set-aside designation,...
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products, was awarded a delivery order valued at $5,189.76 on May 28, 2025, by the Defense Logistics Agency Medical Supply Chain. The contract, designated as delivery order 4568393753 for the SMALL INTERLOCK II product, is structured as a fixed-price agreement with economic price adjustment provisions and carries an ultimate completion date of June 17, 2025. This award was made without any set-aside...
- Nuvasive, Inc., a San Diego-based medical device company specializing in spinal surgery products and services, was awarded a delivery order valued at $1,956.60 by the Defense Logistics Agency Medical Supply Chain on May 8, 2025. This fixed-price delivery order with economic price adjustment mechanism carries an ultimate completion date of May 9, 2025, and is not associated with any set-aside designation, indicating open market competition. The contract supports the federal healthcare system's...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $21,266.40 by the Defense Logistics Agency (DLA) Medical Supply Chain on December 10, 2025. This firm fixed-price delivery order with economic price adjustment mechanisms is scheduled for completion by December 31, 2025, and will be performed at Nuvasive's San Diego facility. The contract carries no set-aside designation, reflecting Nuvasive's...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, was awarded a delivery order valued at $1,956.60 on December 12, 2025, by the Defense Logistics Agency Medical Supply Chain. This fixed-price delivery order with economic price adjustment provisions is scheduled for completion by January 6, 2026, and involves the supply of MAXCESS spinal surgical products and related medical devices to support federal...
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products, was awarded a $13,877.52 fixed-price delivery order (Contract No. 4569002143) by the Defense Logistics Agency Medical Supply Chain on August 4, 2025. The delivery order, designated "SMALL INTERLOCK II," includes economic price adjustment provisions and calls for performance in San Diego, California, with an ultimate completion date of August 5, 2025. This award was made without...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $55,910.77 on December 11, 2025, for reline open implants under contract 4570278357. This fixed-price delivery order with economic price adjustment mechanisms is funded through the Defense Logistics Agency Medical Supply Chain, which procures medical supplies and equipment for Department of Defense and Department of Veterans Affairs healthcare...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, was awarded a $2,438.82 fixed-price delivery order with economic price adjustment by the Defense Logistics Agency Medical Supply Chain on December 10, 2025, for ultimate completion by December 11, 2025. This delivery order, designated as contract M5, carries no set-aside restrictions and represents an open market procurement. The award funds the supply of...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $9,642.60 by the Defense Logistics Agency Medical Supply Chain on December 11, 2025. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries no set-aside designation, reflecting successful competition in an open market procurement. The award is scheduled for completion by January 2, 2026, with...
- Nuvasive, Inc., a San Diego-based medical device manufacturer, was awarded a delivery order valued at $1,956.60 by the Defense Logistics Agency Medical Supply Chain on November 28, 2025, with an ultimate completion date of January 5, 2026. This fixed-price delivery order with economic price adjustment mechanism is for MAXCESS spinal surgical products and related medical technologies. The award was issued under an open market competitive procurement with no set-aside designation, reflecting...
- SPE2DE21D7010Indefinite Delivery Contract
- SPE2DE21D7010-SPE2D626F72R9Delivery Order
Nuvasive, Inc., a San Diego-based medical device manufacturer, was awarded a delivery order valued at $10,273.52 on January 2, 2026, for the supply of SMALL INTERLOCK II spinal implants. This fixed-price delivery order with economic price adjustment mechanisms is funded through the Defense Logistics Agency Medical Supply Chain, which procures medical supplies and equipment for Department of Defense and Department of Veterans Affairs healthcare facilities. The contract carries no set-aside designation, indicating that Nuvasive competed successfully in an open market procurement. Performance is scheduled for completion by January 23, 2026, with all work conducted at Nuvasive's facility in San Diego, California 92121. This delivery order is issued under the broader $8 million Blanket Purchase Agreement held between Transplant Technology Inc. (Nuvasive's parent company) and the Defense Health Agency, structured as an Indefinite Delivery/Indefinite Quantity contract vehicle effective through March 2027. The BPA framework enables streamlined procurement and rapid ordering of Nuvasive's comprehensive portfolio of spinal fusion devices, implants, surgical instruments, and biologics across Department of Defense and Department of Veterans Affairs medical facilities. Nuvasive's sustained capability in delivering critical orthopedic and neurosurgical technologies supports the operational readiness and medical mission effectiveness of federal healthcare enterprises serving active-duty military personnel and veterans nationwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.3k | 1/1/26 |